关注
Robert K Mahar
Robert K Mahar
其他姓名Robert Mahar
Senior Research Fellow, University of Melbourne
在 unimelb.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation
CM Algie, RK Mahar, HB Tan, G Wilson, PD Mahar, J Wasiak
Cochrane Database of Systematic Reviews, 2015
1402015
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe
SYC Tong, J Mora, AC Bowen, MP Cheng, N Daneman, AL Goodman, ...
Clinical Infectious Diseases 75 (11), 2027-2034, 2022
402022
Interventions for reducing wrong‐site surgery and invasive clinical procedures
CM Algie, RK Mahar, J Wasiak, L Batty, RL Gruen, PD Mahar
Cochrane Database of Systematic Reviews, 2015
292015
A scoping review of studies using observational data to optimise dynamic treatment regimens
RK Mahar, MB McGuinness, B Chakraborty, JB Carlin, MJ IJzerman, ...
BMC medical research methodology 21, 1-13, 2021
212021
Peer Reviewed: The Joint Effect of Physical Multimorbidity and Mental Health Conditions Among Adults in Australia
M Ishida, ESG Hulse, RK Mahar, J Gunn, R Atun, B McPake, N Tenneti, ...
Preventing Chronic Disease 17, 2020
212020
Lack of transparency in software used to analyze multiple breath washout data
RK Mahar, D Vukcevic, L King, JB Carlin, S Ranganathan
Pediatric Pulmonology 51 (11), 1108-1110, 2016
122016
Anticoagulation strategies in non–critically ill patients with Covid-19
ZK McQuilten, B Venkatesh, V Jha, J Roberts, SC Morpeth, JA Totterdell, ...
NEJM Evidence 2 (2), EVIDoa2200293, 2023
112023
Statistical analyses of ordinal outcomes in randomised controlled trials: protocol for a scoping review
CJ Selman, KJ Lee, CL Whitehead, BJ Manley, RK Mahar
Trials 24 (1), 1-7, 2023
62023
Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol
D de Kretser, J Mora, M Bloomfield, A Campbell, MP Cheng, S Guy, ...
Clinical Infectious Diseases, ciad666, 2023
62023
A randomized trial of nafamostat for Covid-19
SC Morpeth, B Venkatesh, JA Totterdell, GM McPhee, RK Mahar, M Jones, ...
NEJM Evidence 2 (11), EVIDoa2300132, 2023
52023
Improving clinical trials using Bayesian adaptive designs: a breast cancer example
W Hong, SA McLachlan, M Moore, RK Mahar
BMC Medical Research Methodology 22 (1), 133, 2022
42022
Bayesian modelling of lung function data from multiple‐breath washout tests
RK Mahar, JB Carlin, S Ranganathan, AL Ponsonby, P Vuillermin, ...
Statistics in medicine 37 (12), 2016-2033, 2018
42018
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents …
A Pereira-Salgado, A Anton, F Franchini, RK Mahar, EM Kwan, S Wong, ...
Expert review of pharmacoeconomics & outcomes research 23 (2), 231-239, 2023
22023
Transparent reporting of adaptive clinical trials using concurrently randomised cohorts
IC Marschner, M Jones, JA Totterdell, RK Mahar, TL Snelling, SYC Tong
BMJ medicine 2 (1), 2023
22023
Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19
Z McQuilten, B Venkatesh, V Jha, J Roberts, S Morpeth, J Totterdell, ...
Blood 140 (Supplement 1), 326-328, 2022
22022
A general Bayesian approach to design adaptive clinical trials with time-to-event outcomes
JM McGree, AM Overstall, M Jones, RK Mahar
arXiv preprint arXiv:2303.00901, 2023
12023
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials
MP Hernández-Mitre, SC Morpeth, B Venkatesh, TE Hills, J Davis, ...
INPLASY-International Platform of Registered Systematic Review and Meta …, 2023
1*2023
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value
P Gillett, RK Mahar, NR Tran, M Rosenthal, M IJzerman
Cost Effectiveness and Resource Allocation 21 (1), 87, 2023
2023
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (vol 75, pg 2027, 2022)
N Anagnostou, S Archuleta, E Athan, L Barina, E Best, M Bloomfield, ...
OXFORD UNIV PRESS INC, 2023
2023
Outcome-adaptive randomisation in a multi-arm breast cancer trial
W Hong, SA McLachlan, M Moore, RK Mahar
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20